T-cell recognition of differentially tolerated epitopes of cartilage proteoglycan aggrecan in arthritis. 2005

Edit I Buzás, and Anikó Végvári, and Yanal M Murad, and Alison Finnegan, and Katalin Mikecz, and Tibor T Glant
Section of Biochemistry and Molecular Biology, Department of Orthopedic Surgery, Biochemistry, Immunology/Microbiology, and Internal Medicine (Section of Rheumatology), Rush University Medical Center, Chicago, IL 60612, USA.

Proteoglycan (PG) aggrecan, a major macromolecular component of cartilage, is highly immunogenic; it induces arthritis in genetically susceptible BALB/c mice. The present study maps the T-cell epitope repertoire of cartilage PG by identifying a total of 27 distinct T-cell epitopes. An epitope hierarchy, accounting for the different effector functions of PG-specific T cells, and determinant spreading, has been found. T-cell responses to four epitopes were associated with arthritis induction. Some of the T-cell epitopes were full T-cell activators, whereas a number of subdominant and cryptic epitopes proved to be partial activators in vitro, inducing either cytokine secretion or T-cell proliferation, but not both. A few T-cell epitopes of the core protein of cartilage PG were clearly recognized by T cells in PG-immunized arthritic animals, but the corresponding peptides did not induce T-cell responses when injected into naive BALB/c mice; thus these T-cell epitopes were designated as "conditionally immunogenic."

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011509 Proteoglycans Glycoproteins which have a very high polysaccharide content. Proteoglycan,Proteoglycan Type H
D002356 Cartilage A non-vascular form of connective tissue composed of CHONDROCYTES embedded in a matrix that includes CHONDROITIN SULFATE and various types of FIBRILLAR COLLAGEN. There are three major types: HYALINE CARTILAGE; FIBROCARTILAGE; and ELASTIC CARTILAGE. Cartilages
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D001168 Arthritis Acute or chronic inflammation of JOINTS. Oligoarthritis,Polyarthritis,Arthritides,Oligoarthritides,Polyarthritides

Related Publications

Edit I Buzás, and Anikó Végvári, and Yanal M Murad, and Alison Finnegan, and Katalin Mikecz, and Tibor T Glant
January 2010, Annals of the rheumatic diseases,
Edit I Buzás, and Anikó Végvári, and Yanal M Murad, and Alison Finnegan, and Katalin Mikecz, and Tibor T Glant
May 2014, Immunology,
Edit I Buzás, and Anikó Végvári, and Yanal M Murad, and Alison Finnegan, and Katalin Mikecz, and Tibor T Glant
January 2016, PloS one,
Edit I Buzás, and Anikó Végvári, and Yanal M Murad, and Alison Finnegan, and Katalin Mikecz, and Tibor T Glant
April 2016, Immunology,
Edit I Buzás, and Anikó Végvári, and Yanal M Murad, and Alison Finnegan, and Katalin Mikecz, and Tibor T Glant
September 1995, Clinical and experimental immunology,
Edit I Buzás, and Anikó Végvári, and Yanal M Murad, and Alison Finnegan, and Katalin Mikecz, and Tibor T Glant
September 1995, Journal of immunology (Baltimore, Md. : 1950),
Edit I Buzás, and Anikó Végvári, and Yanal M Murad, and Alison Finnegan, and Katalin Mikecz, and Tibor T Glant
April 1998, The Journal of clinical investigation,
Edit I Buzás, and Anikó Végvári, and Yanal M Murad, and Alison Finnegan, and Katalin Mikecz, and Tibor T Glant
April 1993, Immunology,
Edit I Buzás, and Anikó Végvári, and Yanal M Murad, and Alison Finnegan, and Katalin Mikecz, and Tibor T Glant
November 2001, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit,
Edit I Buzás, and Anikó Végvári, and Yanal M Murad, and Alison Finnegan, and Katalin Mikecz, and Tibor T Glant
October 1992, Cellular immunology,
Copied contents to your clipboard!